University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
NCT Number: NCT01848951
This study will compare the infiltrative transversusabdominis plane (TAP) block with liposomal bupivacaine to epidural analgesia (EA) in major abdominal surgery . The efficacy of the TAP block for abdominal surgery is well documented in literature, but there are no studies utilizing long-acting bupivacaine. The investigators believe the study will demonstrate no difference between the two in terms of pain scores and opioid consumption, but TAP blocks will decreased costs, urinary retention, and hypotension.
Looking for future studies?
Notify Me19 year and older
All sexes
Observational
Omaha, Nebraska, 68198, United States
This study intends to examine this rational by comparing the infiltrative transversusabdominis plane (TAP) block with liposomal bupivacaine to EA in major abdominal surgery. The efficacy of the TAP block for abdominal surgery is well documented in the literature, but there are no studies utilizing long-acting bupivacaine. The investigators believe the primary outcome will demonstrate no difference between the two in terms of pain scores and opioid consumption. The investigators anticipate that patients who have undergone TAP blocks will have improved secondary outcomes with respect to a decreased costs, urinary retention, and hypotension.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The skin will be disinfected with 2% chlorhexidine. Under sterile technique, the epidural will be placed. Epidural catheter will be placed at thoracic vertebral levels T5 to T10. Level chosen as clinically indicated. The epidural solution should contain institution's standard solution of Bupivicaine 0.05% and hydromorphone 10 mcg/cc. However, solution type should be clinically indicated.
Other names: local anesthetic
The skin will be disinfected with 2% chlorhexidine. The bilateral dual TAP infiltrative blocks will be placed using high-frequency ultrasound. The TAP blocks will be performed using lipospheric bupivacaine (Exparel) with the following dosing regimen.A 266mg (20cc) vial of lipospheric bupivacaine will be equally into 2 30 ml syringes using strict sterile technique. The solution will be diluted in each syringe with 20cc preservative free sterile 0.9% normal saline to a total volume of 30 ml in each syringe. Once the transversus abdominal plane is identified then a 5-10 ml of plain 0.9% normal saline will be injected to open the fascial plane. Once the plane is opened then the 15cc of diluted lipospheric bupivacaine will be administered under direct ultrasound visualization in all 4 TAP quadrants (subcostal position x2 and lateral position x2)
Other names: transversus abdominis plane, abdominal muscle anesthesia
Time frame: 96 hours post-op
Comparison of pain scores (0 = no pain to 10 = worst pain possible)
Time frame: 96 hours post-op
A comparison of opioid consumption in a 24-Hour period at 96 hours post-op between the interventions
Time frame: 96 hours post-op
Comparison of 96-hour hospital stay cost between the interventions
Time frame: 96 hours post-op
Comparison of urinary failure/catheter acquired infection rates between the interventions
Time frame: 96 hours post-op
Comparison hypotension rates between the interventions
University of Nebraska
Other
Comparison of Epidural Analgesia With Bilateral Dual TAP Infiltration Block With Liposomal Bupivacaine in Patients With Major Abdominal Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07101835
Acute Pain, Body Weight
Samsun, Turkey (Türkiye)
View Trial DetailsNCT05370404
Acute Pain, Neurologic Manifestations
Ann Arbor, Michigan, United States
View Trial DetailsNCT05764616
Acute Pain, Agnosia
Rome, Italy
View Trial DetailsNCT03860259
Acute Pain, Arthralgia
Pittsburgh, Pennsylvania, United States
View Trial Details